History | Acne vulgaris: management | Guidance | NICE

History

A list of downloadable documents created during development.

Stakeholder list updated

Stakeholder list ^{PDF 119 KB} 25 June 2021

Declaration of interests

Register of interests ^{PDF 406 KB} 25 June 2021

Guidance published

Committee member list ^{PDF 134 KB} 25 June 2021
Supporting documentation acknowledgements ^{PDF 188 KB} 25 June 2021
Consultation comments and responses ^{PDF 974 KB} 25 June 2021
Equality impact assessment 4 & 5 ^{PDF 201 KB} 25 June 2021

Draft guidance consultation

Draft guidance consultation
Draft guideline ^{PDF 652 KB} 18 December 2020
Evidence review A - Information and support ^{PDF 675 KB} 18 December 2020
Evidence review B - Skin care advice ^{PDF 1.16 MB} 18 December 2020
Evidence review C - Diet ^{PDF 1.11 MB} 18 December 2020
Evidence review D - Referral to specialist care ^{PDF 702 KB} 18 December 2020
Evidence review E1 - Mild to moderate acne ^{PDF 10.82 MB} 18 December 2020
Evidence review E2 - Mild to moderate pairwise analysis ^{PDF 4.31 MB} 18 December 2020
Evidence review F1 - Moderate to severe acne ^{PDF 8.13 MB} 18 December 2020
Evidence review F2 - Moderate to severe pairwise analysis ^{PDF 3.69 MB} 18 December 2020
Evidence review G - Polycystic ovary syndrome ^{PDF 2.33 MB} 18 December 2020
Evidence review H - Refractory acne ^{PDF 2.06 MB} 18 December 2020
Evidence review I - Maintenance treatment ^{PDF 3.11 MB} 18 December 2020
Evidence review J - Oral corticosteroids + oral isotretinoin ^{PDF 885 KB} 18 December 2020
Evidence review K - Intralesional steroids ^{PDF 706 KB} 18 December 2020
Evidence review L - Risk factors for scarring ^{PDF 833 KB} 18 December 2020
Evidence review M - Management of scarring ^{PDF 4.07 MB} 18 December 2020
Supporting documentation - Method ^{PDF 485 KB} 18 December 2020
Supporting documentation - NGA team and collaborators from the TSU ^{PDF 186 KB} 18 December 2020
Supporting documentation - TSU NMA software code (mild to moderate acne) ^{PDF 482 KB} 18 December 2020
Supporting documentation - NMA data (mild to moderate acne) ^{Excel 154 KB} 18 December 2020
Supporting documentation - NMA of efficacy included and excluded studies (mild to moderate acne) ^{Excel 43 KB} 18 December 2020
Supporting documentation - NMA, direct and indirect estimates (mild to moderate acne ^{Excel 138 KB} 18 December 2020
Supporting documentation - TSU NMA software code (moderate to severe acne) ^{PDF 464 KB} 18 December 2020
Supporting documentation - NMA data (moderate to severe acne) ^{Excel 114 KB} 18 December 2020
Equality impact assessment - section 3 ^{PDF 267 KB} 18 December 2020
Comments form ^{MSWord 37 KB} 18 December 2020

Pre-consultation documents released

Economic plan ^{PDF 106 KB} 02 November 2020
Review questions ^{PDF 212 KB} 02 November 2020
Search strategies ^{PDF 1.54 MB} 02 November 2020

Committee meetings

Committee meeting
Minutes - GC1 ^{PDF 211 KB} 01 February 2019
Minutes - GC2 ^{PDF 190 KB} 08 March 2019
Minutes - GC3 ^{PDF 174 KB} 26 April 2019
Minutes - GC4 ^{PDF 230 KB} 07 June 2019
Minutes - GC5 ^{PDF 187 KB} 25 July 2019
Minutes - GC6 ^{PDF 232 KB} 28 October 2019
Minutes - GC7 ^{PDF 236 KB} 11 October 2019
Minutes - GC8 ^{PDF 217 KB} 29 November 2019
Minutes - GC9 ^{PDF 215 KB} 29 January 2020
Minutes - GC10 & 11 ^{PDF 250 KB} 05 March 2020
Minutes - GC12A ^{PDF 218 KB} 20 July 2020
Minutes - GC12B ^{PDF 216 KB} 07 August 2020
Minutes - GC13 ^{PDF 248 KB} 02 September 2020
Minutes - GC14 ^{PDF 192 KB} 18 September 2020
Minutes - GC 15 ^{PDF 186 KB} 09 October 2020
Minutes GC16 ^{PDF 213 KB} 25 February 2021

Scope published

Final scope ^{PDF 317 KB} 15 January 2019
Equality impact assessment 2 ^{PDF 398 KB} 17 April 2019
Consultation comments and responses ^{PDF 419 KB} 02 May 2019

Draft scope consultation

Draft scope consultation
Draft scope ^{PDF 349 KB} 24 September 2018
Comments form ^{MSWord 31 KB} 24 September 2018
Equality impact assessment 1 ^{PDF 230 KB} 17 April 2019

Scoping workshop: London

Workshop notes ^{PDF 173 KB} 01 May 2019